Journal
JOURNAL OF ANTIBIOTICS
Volume 75, Issue 1, Pages 9-15Publisher
SPRINGERNATURE
DOI: 10.1038/s41429-021-00484-5
Keywords
-
Funding
- JSPS KAKENHI [19K05855]
- Faculty of Agriculture, Kindai University
- Grants-in-Aid for Scientific Research [19K05855] Funding Source: KAKEN
Ask authors/readers for more resources
Seriniquinone, originally isolated from marine bacteria, is a melanoma-selective anti-cancer agent with unique target. Its derivatives, synthesized through biological transformation and chemical methods, exhibit selective cytotoxic activity against melanoma with improved solubility.
Seriniquinone was originally isolated as a melanoma-selective anti-cancer agent from a culture broth of marine bacteria. Pharmacological studies on its selectivity and unique target are ongoing. A new dihydronaphthothiophene (1) was synthesized by the biological transformation of seriniquinone using marine-derived actinomycete Streptomyces albogriseolus OM27-12, and its derivatives (2-4) were chemically synthesized. Compounds 1-4 exhibited selective cytotoxic activity against melanoma and improved solubility.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available